Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial
about
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision lossLong-term Outcomes in Youths with Diabetes MellitusType 1 diabetesGlycemic control and cardiovascular disease: what's a doctor to do?Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathyQuality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyEpigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylationNa+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosisDifferential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 DiabetesGene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes.Molecular mechanisms of diabetic vascular complicationsBiomarkers in Diabetic RetinopathyPractical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes ManagementMetabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytesEffect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyChronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study.Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon.Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression.Metabolic memory: a vascular perspective.Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications studyReview of therapeutic advances in diabetic retinopathy.Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy.Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyThe 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.Fetal environment, epigenetics, and pediatric renal disease.Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylationLong-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study.Prediction of retinopathy at 20 years after onset in younger-onset type 1 diabetes using mean metabolic memory-free HbA1c values: the importance of using HbA1c data of total, not partial, diabetes durationEffect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDICFurther insight on the limits of success of glycemic control in type 1 diabetes.Anti-vascular endothelial growth factor therapy for diabetic macular edemaEvolving strategies in the management of diabetic retinopathyAllosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness.A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose.Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization Questionnaire.
P2860
Q26775552-177B98CB-F7E9-4104-B315-A058030059C0Q26799531-43B10B80-7A5D-4B9A-A5FF-43E65309C694Q27000491-2EE79035-87E9-46CB-9985-C0CDECE14162Q27024469-6CAAE1D8-F912-482C-9C62-C665997CEBE5Q28476732-6CCBC39E-7240-465F-8F4C-7F8B4DABBC43Q28550615-B26DBA8B-ADD2-4AC1-A3A8-D3FABD7D3C70Q28578457-5EB6FBC8-429D-404B-8654-E567FA5B6DB3Q28581192-68807ABA-1D5E-4462-B1F4-8B04B6E5F059Q30300141-A86B96B4-C123-46FE-A5A0-95E42029BB58Q30422127-EE5D755B-38B2-424D-9108-C65D4ADBC5A1Q33558421-3C9D5D20-8F3C-4C89-A108-7AF501361763Q33583030-D19B150A-D6AC-4F2D-82B5-B26AB022D3D2Q33621582-5C56611B-963F-4630-A81B-AAA93A5CFB5FQ33801797-529F55AA-00D0-4792-A576-5A715BF557BEQ33803493-277D5BA9-CD99-4525-BD21-82375D3C55F0Q33804684-7F681B5E-42E7-4B37-9831-9CFC2722ABC4Q33901377-AFAD14D9-B117-416A-BD5B-8B76BB424270Q33914662-9EAB518D-7F9C-4D2F-B725-0D970BF7FA9DQ34009114-E1755C26-48A9-4593-A755-E394ED9FBA85Q34071861-E580EC81-B4C7-4CC5-B258-3EB5542FD480Q34110092-7D6BB7C6-0C49-4E87-B846-1BAE96CC3489Q34158068-DF5DC7CA-8E12-4715-B10F-4D428E97E3D9Q34433105-D9B467B9-2727-4BDE-98F7-1E44DB3390F4Q34475449-331B1899-C3A8-450C-90FE-A23E3141BA0AQ34481039-BCFF6AB6-9C3A-4327-973B-42235282EF0AQ34511162-960D16C6-6186-4260-92D7-BE1A61E5E17BQ34526936-52CEBDF1-D0BD-42CE-B083-0C9B612F0DBDQ34625920-DEE9A25E-4A46-42F0-9F58-3D032394A7F7Q34666690-C678ED1F-19BB-42C7-844C-C5E55C8E39DEQ34666874-79CD47B2-D1C6-43F9-805E-B30F790E7C5BQ34762641-125CB3F4-6B36-4E4F-8793-3699C2C8D513Q34985431-87574EB2-6516-4822-9B62-1E5755AEB251Q35004314-C7E6054B-7F07-4288-A2F9-11EC99045D7EQ35004364-9767846C-5BA7-4F40-99C9-5AE8AE2184F4Q35064343-4F4CC46C-3960-4EBA-AF5D-EFC037732E23Q35067102-93CF74C4-22BE-4354-8F36-57A0F62EB541Q35084192-ECCD1A86-7D42-4ACE-9D97-7B32E5929A8DQ35300956-B17A9B0F-AE9A-471F-A07F-219289B9DFC6Q35591570-FF11275F-BB49-4B9C-B9D1-7BEC7CE67D63Q35612335-B8C70BC6-BA73-4ACF-91D0-234D2B03AEA7
P2860
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolonged effect of intensive ...... ontrol and Complications Trial
@en
Prolonged effect of intensive ...... ntrol and Complications Trial.
@nl
type
label
Prolonged effect of intensive ...... ontrol and Complications Trial
@en
Prolonged effect of intensive ...... ntrol and Complications Trial.
@nl
prefLabel
Prolonged effect of intensive ...... ontrol and Complications Trial
@en
Prolonged effect of intensive ...... ntrol and Complications Trial.
@nl
P2093
P2860
P1433
P1476
Prolonged effect of intensive ...... ontrol and Complications Trial
@en
P2093
David M Nathan
Dean P Hainsworth
Larry D Hubbard
Matthew D Davis
Neil H White
Patricia A Cleary
Ronald P Danis
Wanjie Sun
P2860
P304
P356
10.1001/ARCHOPHT.126.12.1707
P407
P577
2008-12-01T00:00:00Z